Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
Joint Authors
Duvoisin, Gilles
Lopez, Robert N.
Leach, Steven T.
Lemberg, Daniel A.
Day, Andrew Stewart
Gearry, R. B.
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-04-16
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
There is increasing importance placed upon noninvasive assessment of gut inflammation.
These tools are likely to be the key in differentiating intestinal inflammatory disease from functional disorders and in monitoring the response to intervention in individuals with known inflammatory conditions.
Although various noninvasive markers are currently available, they have limitations and do not provide ideal utility.
This review focuses on emerging markers of gut inflammation, highlighting the potential of specific markers.
American Psychological Association (APA)
Duvoisin, Gilles& Lopez, Robert N.& Day, Andrew Stewart& Lemberg, Daniel A.& Gearry, R. B.& Leach, Steven T.. 2017. Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators of Inflammation،Vol. 2017, no. 2017, pp.1-9.
https://search.emarefa.net/detail/BIM-1188127
Modern Language Association (MLA)
Duvoisin, Gilles…[et al.]. Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators of Inflammation No. 2017 (2017), pp.1-9.
https://search.emarefa.net/detail/BIM-1188127
American Medical Association (AMA)
Duvoisin, Gilles& Lopez, Robert N.& Day, Andrew Stewart& Lemberg, Daniel A.& Gearry, R. B.& Leach, Steven T.. Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease. Mediators of Inflammation. 2017. Vol. 2017, no. 2017, pp.1-9.
https://search.emarefa.net/detail/BIM-1188127
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1188127